As showed in Table1, patients with high expression of USP39 had a significantly lower survival rate (P < 0.01) and a shorter median survival duration as compared with those in patients with low expression of USP39 (P < 0.01), indicating that the expression level of USP39 was negatively correlated with the survival rate of RCC patients. This evidence concerns the gene USP39 and renal cell carcinoma.